title: Gene expression in obstetric antiphospholipid syndrome: a systematic review.
abstract: BACKGROUND
  Antiphospholipid syndrome (APS) is a multisystem disease that may present as venous or arterial thrombosis and/or pregnancy complications with the presence of antiphospholipid antibodies. Until today, heterogeneity of pathogenic mechanism fits well with various clinical manifestations. Moreover, previous studies have indicated that genes are differentially expressed between normal and in the disease state. Hence, this study systematically searched the literature on human gene expression that was differentially expressed in Obstetric APS.
  
  
  METHODS
  Electronic search was performed until 31st March 2015 through PubMed and Embase databases; where the following Medical Subject Heading (MeSH) terms were used and they had been specified as the primary focus of the articles; gene, antiphospholipid, obstetric, and pregnancy in the title or abstract. From 502 studies retrieved from the search, only original publications that had performed gene expression analyses of human placental tissue that reported on differentially expressed gene in pregnancies with Obstetric APS were included. Two reviewers independently scrutinized the titles and the abstracts before examining the eligibility of studies that met the inclusion criteria. For each study; diagnostic criteria for APS, method for analysis, and the gene signature were extracted independently by two reviewers. The genes listed were further analysed with the DAVID and the KEGG pathways.
  
  
  RESULTS
  Three eligible gene expression studies involving obstetric APS, comprising the datasets on gene expression, were identified. All three studies showed a reduction in transcript expression on PRL, STAT5, TF, DAF, ABCA1, and HBEGF in Obstetric APS. The high enrichment score for functionality in DAVID had been positive regulation of cell proliferation. Meanwhile, pertaining to the KEGG pathway, two pathways were associated with some of the listed genes, which were ErBb signalling pathway and JAK-STAT signalling pathway.
  
  
  CONCLUSIONS
  Ultimately, studies on a genetic level have the potential to provide new insights into the regulation and to widen the basis for identification of changes in the mechanism of Obstetric APS.
authors.affiliation: Universiti Sains Islam Malaysia, Faculty of Medicine and Health Science, Kuala Lumpur, Malaysia. wirda@usim.edu.my.
authors.forename: M
authors.initials: M
authors.lastname: Muhammad Aliff
authors.forename: S
authors.initials: S
authors.lastname: Muhammad Shazwan
authors.forename: M M
authors.initials: MM
authors.lastname: Nur Fariha
authors.forename: A R
authors.initials: AR
authors.lastname: Hayati
authors.forename: A R
authors.initials: AR
authors.lastname: Nur Syahrina
authors.forename: M
authors.initials: M
authors.lastname: Maizatul Azma
authors.forename: A H
authors.initials: AH
authors.lastname: Nazefah
authors.forename: S
authors.initials: S
authors.lastname: Jameela
authors.forename: A A
authors.initials: AA
authors.lastname: Asral Wirda
mesh_terms: D016736:Antiphospholipid Syndrome / Q000235:genetics*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000235:genetics* / Q000276:immunology*; D059467:Transcriptome / Q000235:genetics*